Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today reported financial results for the three- and twelve-month periods ended December 31, 2017. Recent Company Highlights: Generated net sales of $3.1 million in the fourth quarter of 2017 and $8.0 million for the full yea